Elizabeth Finger

Publications

• CTGF is a therapeutic target for metastatic melanoma. Finger EC, Cheng CF, Williams TR, Rankin EB, Bedogni B, Tachiki L, Spong S, Giaccia AJ, Powell MB. Oncogene. 2013
• TBC1D16 is a Rab4A GTPase activating protein that regulates receptor recycling and EGF receptor signaling. Goueli BS, Powell MB, Finger EC, Pfeffer SR. Proc Natl Acad Sci U S A. 2012; 109 (39): 15787-92
• VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKC{delta}-driven migration. Razorenova OV, Finger EC, Colavitti R, Chernikova SB, Boiko AD, Chan CK, Krieg A, Bedogni B, LaGory E, Weissman IL, Broome-Powell M, Giaccia AJ. Proc Natl Acad Sci U S A. 2011; 108 (5): 1931-6
• Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Finger EC, Giaccia AJ. Cancer Metastasis Rev. 2010; 29 (2): 285-93
• Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation. Finger EC, Lee NY, You HJ, Blobe GC. J Biol Chem. 2008; 283 (50): 34808-18
• TbetaRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity. Finger EC, Turley RS, Dong M, How T, Fields TA, Blobe GC. Carcinogenesis. 2008; 29 (3): 528-35
• The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer. Turley RS, Finger EC, Hempel N, How T, Fields TA, Blobe GC. Cancer Res. 2007; 67 (3): 1090-8